Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Evozyne Announces a Strategic Collaboration for Development of Novel Biopharmaceutical Therapeutics
Tuesday, February 02, 2021Evozyne LLC a privately held molecular engineering technology company founded by life science innovator Paragon Biosciences announced the signing of a strategic collaboration with a leading company in rare disorders for the development and commercial...
ZebiAI and TB Alliance Announce Collaboration to Apply ML-Driven Discovery Platform to Tuberculosis Targets
Tuesday, February 02, 2021ZebiAI Inc a biotech company focused on improving human health by powering machine learning ML to source novel targets and discover new therapeutics today announced a strategic collaboration agreement with TB Alliance a notforprofit organization dedi...
Phase 1 Drug Candidate GLR2007, Developed by Gan & Lee, Received Fast Track Designation from the US FDA
Monday, February 01, 2021Gan Lee Pharmaceuticals Co an international biopharmaceutical companyannounced that the Food and Drug Administration FDA has granted GLR Fast Track designation for the treatment of patients with glioblastoma
Rigel Awarded $16.5 Million from U.S. Department of Defense for Phase 3 Clinical Trial of Fostamatinib in COVID-19 Patients
Saturday, January 30, 2021Rigel Pharmaceuticals Inc announced it has been awarded million by the US Department of Defenses DOD Joint Program Executive Office for Chemical Biological Radiological and Nuclear Defense JPEOCBRND
Lilly and Asahi Kasei Pharma Announce License Agreement for Chronic Pain Drug Candidate
Friday, January 29, 2021Eli Lilly and Company and Asahi Kasei Pharma Corporation announced a license agreement whereby Lilly will acquire the exclusive rights for AK from Asahi Kasei Pharma AK is an orally bioavailable PX receptor antagonist that recently completed Phase s...
Hoth Therapeutics Expands Research Collaboration Agreement with Weill Cornell Medicine to Continue the Advancement of HT-003 for Acne Treatment Research
Friday, January 29, 2021Hoth Therapeutics Inc a biopharmaceutical company today announced extending a research collaboration agreement with Weill Cornell Medicine to continue investigating the therapeutic mechanism of action and safety of HT a novel retinoic acid metabolism...
Cognate BioServices and Nucleus Biologics announce partnership in Cell and Gene Therapies
Thursday, January 28, 2021Cognate BioServices Inc the premier commercialready global CDMO in the Cell and Gene Therapy industry and Nucleus Biologics LLC The Cell Performance Company announced a partnership for custom and commercial medias and delivery systems for Cell and Ge...
AbCellera-Discovered Antibody, Bamlanivimab, to be Developed with VIR-7831 for the Treatment of COVID-19
Thursday, January 28, 2021AbCellera announced that bamlanivimab LYCoV a human antibody discovered by AbCellera and developed with Eli Lilly and Company Lilly will be evaluated together with VIR an antibody developed by Vir Biotechnology Inc and GlaxoSmithKline
Care Access Research Collaborates with AstraZeneca on Phase III Clinical Trial for COVID-19 Long-Acting Antibody Combination
Wednesday, January 27, 2021Care Access Research a decentralized research organization DRO that operates as one connected team of physicians and research experts announced a collaboration with global biopharmaceutical company AstraZeneca to accelerate a clinical trial in the US
Agenus Enters into Clinical Collaboration with Nelum for Zalifrelimab Combination
Wednesday, January 27, 2021Agenus Inc an immunooncology company with an extensive pipeline of checkpoint antibodies cell therapies adjuvants and vaccines designed to activate immune response to cancers and infections
